85761-38-2

Basic information

• Product Name: Cyclohexanol, 2-(phenylmethoxy)-, (1R,2R)-
• CAS NO: 85761-38-2
• Molecular Formula: C13H18O2
• Molecular Weight: 206.285
• Mol File: 85761-38-2.mol
• Article Data: 26

Chemical Properties

• CAS DataBase Reference: Cyclohexanol, 2-(phenylmethoxy)-, (1R,2R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanol, 2-(phenylmethoxy)-, (1R,2R)-(85761-38-2)
• EPA Substance Registry System: Cyclohexanol, 2-(phenylmethoxy)-, (1R,2R)-(85761-38-2)

Safety Data

• Hazardous Substances Data: 85761-38-2(Hazardous Substances Data)

Upstream product

• 110-82-7 cyclohexane 
• 100-51-6 benzyl alcohol 
• 286-20-4 cyclohexene oxide 
• 1792-81-0 cis-1,2-cyclohexane 
• 100-39-0 benzyl bromide 
• 84029-20-9 racemic cis-1-benzyloxy-7-oxabicyclo[4.1.0]heptane 
• 32700-48-4 [(cyclohex-2-en-1-yloxy)methyl]benzene 
• 1460-57-7 trans-1,2-cyclohexandiol 
• 84029-20-9 (±)-(1R,2S,6S)-2-(benzyloxy)-7-oxabicyclo[4,1,0]heptane 
• 29494-42-6 1-(benzyloxy)cyclohexene 
• 286-20-4 cyclohexane-1,2-epoxide 
• 1072-86-2 (1R,2R)-trans-1,2-cyclohexanediol 
• 125992-57-6 (1R,2R)-1-(2-benzyloxy)cyclohexyl acetate 
• 100-44-7 benzyl chloride 

Downstream Products

• 85761-39-3 (1S,2S)-cyclohexane-1,2-diol monobenzyl ether 
• 125992-57-6 (1R,2R)-1-(2-benzyloxy)cyclohexyl acetate 
• 880498-21-5 (2R)-2-benzyloxycyclohexanone 
• 1072-86-2 (1R,2R)-trans-1,2-cyclohexanediol 
• 121282-70-0 (+/-)-trans-1-hydroxy-2-tert-butoxycarbonylamino-cyclohexane 
• 931-16-8 (+/-)-trans-2-aminocyclohexanol 
• 98454-42-3 (±)-trans-2-(benzyloxy)cyclohexanamine 
• 85726-60-9 2-Benzyloxycyclohexyl-3,4-di-O-acetyl-2,6-didesoxy-α-L-arabino-hexopyranosid 
• 85726-47-2 2-Oxocyclohexyl-3,4-di-O-acetyl-2,6-didesoxy-α-L-arabino-hexopyranosid 

Relevant articles and documents

CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO

The invention relates to inhibitors of calcium-dependent protein kinase 1 (CDPK1) and pharmaceutical preparations thereof. The invention further relates to methods of treatment of parasitic infections, such as T. gondii, P. falciparum, C. hominis, or C. parvum infections, using the novel inhibitors of the invention.

Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis

Calcium dependent protein kinase 1 (CDPK1) is an essential Ser/Thr kinase that controls invasion and egress by the protozoan parasite Toxoplasma gondii. The Gly gatekeeper of CDPK1 makes it exquisitely sensitive to inhibition by small molecule 1H-pyrazolo

Lanthanide-based coordination polymers as promising heterogeneous catalysts for ring-opening reactions

This work presents the synthesis and structural characterization of Eu3+- and Tb3+-based coordination polymers starting from a Co3+-based metalloligand offering appended arylcarboxylic acid groups. Both coordination polymers function as reusable heterogeneous catalysts for ring-opening reactions utilizing amines, alcohols, thiols, and azides as the nucleophiles. The catalytic results illustrate an excellent control over the regioselectivity whereas a filtration test and mechanistic studies substantiate Lewis-acid catalyzed activation of the epoxide during the reaction.